SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as its community rallies around a shared vision, emphasizing their strong belief in the project's long-term success, particularly within the Solana ecosystem. Active community members are encouraging each other to stay focused and united, aiming to outperform other projects. The community's enthusiasm is palpable, with members expressing readiness for upcoming developments.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

SLAP is trending as the community rallies around the project's unique approach to crypto, which includes staking rewards, real-world events, and support from pro athletes. Community members highlight the team's active engagement and efforts to onboard newcomers to web3. The discussion also includes questions about the project and its overall direction.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Dog (Bitcoin) is trending as the community buzzes around potential catalysts and upcoming integrations like ZAP. Some users highlight the coin's strong community and potential for growth within the Bitcoin ecosystem, with many expressing a bullish outlook.

this coin is scarce

SCARCE CRYPTO is trending as traders discuss its potential for a breakout, citing a tightening chart pattern and signs of accumulation. The community believes the coin exhibits disciplined strength and is coiling for a significant move, with some suggesting it's still early to load up.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The 'crow with knife' meme coin is gaining traction across multiple chains, with the community emphasizing its fully circulated supply and organic growth. Discussions highlight its deflationary nature and potential staking opportunities. The community buzz reflects excitement about its potential to disrupt the meme coin landscape.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Strike Coin

Strike Coin ($STRK) is trending as the community highlights its privacy and scaling solutions, particularly its relationship with Zcash ($ZEC). Discussions focus on Starknet's potential to bring privacy to Layer 2 and its potential for significant rallies.  Some community members are also noting the current ticker may not be Starknet.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending with community members weighing in on potential price movements and key support levels, especially in light of recent market volatility. Some traders are capitalizing on price swings, while others are focused on the long-term potential and accumulating more $SOL. The conversation also includes discussion of Solana-based meme coins and new ETF filings.

GraniteShares ETF Trust - GraniteShares 2x Long MARA Daily ETF

GraniteShares 2x Long MARA Daily ETF

MRAL is trending as traders discuss its leveraged exposure to MARA, a Bitcoin mining company, and its potential for outsized gains. Community members are weighing the potential impact of upcoming earnings and Bitcoin's price movements on the ETF. Some traders are actively swapping MARA shares for MRAL, anticipating a significant upward move.

Amentum Holdings, Inc. provides mission-critical, technology-driven services in government and commercial markets. It operates through two operating segments: Critical Mission Solutions and Cyber & Intelligence. The Critical Mission Solutions segment provides test, training, and operations services for missile defense systems, IT and engineering services to defense clients and the space sector, technological solutions, including installations, decommissioning, and environmental remediation to energy clients, and other highly technical consulting solutions. The Cyber & Intelligence segment provides advanced cyber training and data analytics for government professionals, advanced communication systems and aerial mapping technologies to national security clients, and other technical services for United States defense and intelligence clients. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum Holdings (AMTM) is trending as investors discuss its substantial $44.6 billion backlog and potential long-term value, particularly with government contracts. Community chatter also revolves around options strategies and speculation regarding future deals, including potential involvement in projects like the U.S. Space Force's "Death Star." However, some traders are expressing concerns over the stock's bearish short-term trend, evidenced by its price trading below key moving averages.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around the project's ethos of perseverance, even when "everything broken." The community is expressing bullish sentiment and emphasizing its strength, while also highlighting the utility provided by Broke Perspective. There is ongoing discussion around community collaboration with $CAW, $DOG, $RAGE and others, with community members using terms like $WAGMI (We Are All Going to Make It) and calling for others to $SLAP (buy).

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Maze Therapeutics (NASDAQ:MAZE) Sees Strong Trading Volume - Here's Why

Maze Therapeutics (NASDAQ:MAZE) Sees Strong Trading Volume - What's Next...

Maze Therapeutics (NASDAQ:MAZE) Given New $36.00 Price Target at Wedbush

Wedbush upped their price objective on Maze Therapeutics from $35.00 to $36.00 and gave the company an "outperform" rating in a research note on Friday...

Maze Therapeutics (NASDAQ:MAZE) Releases Earnings Results, Beats Expectations By $0.08 EPS

Maze Therapeutics (NASDAQ:MAZE - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.66) earnings per share (EPS) for the quarter, beating the consensus...

Maze Therapeutics (NASDAQ:MAZE) Stock Price Down 9.6% - Here's What Happened

Maze Therapeutics (NASDAQ:MAZE) Trading Down 9.6% - Here's What Happened...

Maze Therapeutics CEO Jason Coloma on how the new biotech is taking on Kidney disease

(OPTIMIZED VIDEO SPECIFIC DESCRIPTION) For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/42d859g Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision...

Maze Therapeutics, Inc. (MAZE) on Thursday announced that it has entered into a securities purchase agreement for the private placement of its securities for gross proceeds of about $150 million. Shares of the company soared 56% in the pre-market session at the time of writing.The <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.mazetx.com/news-releases/news-release-details/maze-therapeutics-announces-oversubscribed-1500-million-private">private placement</a> involves the sale of over four million shares of common stock at $16.25 &nbsp;apiece, implying a premium of over 1% from the stock’s closing price on Wednesday. The placement is expected to close on September 12, the company said, while adding that both new and existing investors will participate.The firm said that the private placement includes participation from Frazier Life Sciences, Deep Track Capital, Driehaus Capital Management, Janus Henderson Investors, Logos Capital, TCGX, and Venrock Healthcare Capital Partners, as well as other healthcare-dedicated funds.The South San Francisco-based biopharmaceutical company is developing medicines for patients with kidney and metabolic diseases. It stated that it expects to utilize the proceeds from the placement to advance the development of MZE829 in patients with APOL1-mediated kidney disease, initiate mid-stage clinical trials of MZE782 in both phenylketonuria (PKU) and chronic kidney disease (CKD), and continue progress on its research and discovery programs. The company also intends to use the funds for working capital and other general corporate purposes.Last month, the company said that it ended June with cash and cash equivalents of $264.5 million, which it expects will fund operations into the second half of 2027.Separately, the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.mazetx.com/news-releases/news-release-details/maze-therapeutics-announces-positive-first-human-results-phase-1">also</a> announced positive clinical results from an early-stage study of MZE782, including “an excellent safety profile, robust target engagement and compelling pharmacodynamic effects.” The firm stated that the study data in 112 healthy volunteers exceeded expectations, enabling mid-stage advancement in the treatment of both PKU and CKD in 2026.Maze went public in January. The stock is up by 0.4% since its listing.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-in-consolidation-mike-novogratz-sees-solana-ethereum-taking-spotlight/chwN1oPRdvg">‘Bitcoin in Consolidation’ – Galaxy’s Mike Novogratz Reportedly Sees Solana, Ethereum Taking Spotlight For Now</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Maze Therapeutics Stock Just Shot Up 56% Pre-Market Today – Here’s What Happened

The company announced a private placement for over four million shares of common stock at $16.25 apiece, representing a premium of over 1% from the stock’s closing price on Wednesday.

Equity

The company announced a private placement for over four million shares of common stock at $16.25 apiece, representing a premium of over 1% from the stock’s closing price on Wednesday.


Maze Therapeutics receives positive ratings following recent IPO

Investing.com --  Maze Therapeutics  Inc (NASDAQ:MAZE) received bullish coverage from multiple analysts, with Guggenheim, JPMorgan, and TD Cowen initiating Buy or Overweight ratings on the company given its potential in genetically targeted therapies.

Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM diseases. Its pipeline includes the Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process to refer a variant functionalization. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman on August 29, 2017 and is headquartered in San Francisco, CA.

Maze Therapeutics Inc.

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$32.53
Prev Close	$31.84
Open	$31.99
Dividend Yield	N/A
50-Day Moving Average	$27.53
Beta	1.08
Avg. Volume	329,417.96
PE Ratio	-14.43

52-Week High	$34.29
52-Week Low	$6.71
Market Capitalization	$1.57B
EPS (Annual)	$0.0778
Price to Book	4.12
Revenue Per Employee	$1.34M
Enterprise Value/EBITDA	N/A

MAZE
Maze Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MAZE News

MAZEMaze Therapeutics Inc.